Riluzole Oral Suspension
Brand names: Teglutik, Tiglutik
Category: Neurology
FDA status: Current · Last FDA update: Sep 15, 2026 · First posted: Jan 26, 2024 (in shortage 2 years 8 months) · 1 manufacturers, 4 listed presentations
As of Sep 15, 2026, the FDA lists Riluzole Oral Suspension as currently in shortage. Of 4 manufacturer presentations, 1 Unavailable, 3 Available.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) NDC 70726-0305-1 |
EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Available | - |
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) NDC 70726-0304-1 |
EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Available | - |
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) NDC 70726-0306-1 |
EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Available | - |
| Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1) NDC 70726-0303-1 |
EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Unavailable | Estimated recovery: TBD |
Related medications in shortage
Other Neurology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Riluzole Oral Suspension (FDA data as of Sep 15, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Riluzole Oral Suspension. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/riluzole-oral-suspension.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).